KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy
Abstract Background Cardiovascular diseases have become the leading cause of death worldwide, and cardiac hypertrophy is the core mechanism underlying cardiac defect and heart failure. However, the underlying mechanisms of cardiac hypertrophy are not fully understood. Here we investigated the roles...
Main Authors: | Yi Wang, Hongjuan Liao, Yueheng Wang, Jinlin Zhou, Feng Wang, Yingxin Xie, Kun Zhao, Weinian Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12872-021-02053-y |
Similar Items
-
A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA Expression
by: Yueyang Liu, et al.
Published: (2022-09-01) -
Epigallocatechin gallate (EGCG) attenuates myocardial hypertrophy and fibrosis induced by transverse aortic constriction via inhibiting the Akt/mTOR pathway
by: Yue Cui, et al.
Published: (2021-01-01) -
Hyperactivation of mTOR and AKT in a cardiac hypertrophy animal model of Friedreich ataxia
by: Wing-Hang Tong, et al.
Published: (2022-08-01) -
The protective effect of Apelin-13 against cardiac hypertrophy through activating the PI3K-AKT-mTOR signaling pathway
by: Yu Peng, et al.
Published: (2023-02-01) -
Androgen interacts with exercise through the mTOR pathway to induce skeletal muscle hypertrophy
by: Fanxing Zeng, et al.
Published: (2017-12-01)